Women were less than half of the people tested for almost all of these common medicines.

NCT02153944

Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety

See it on ClinicalTrials.gov ↗

128 people

66 womenmiddle line = equal numbers62 men
Phase
PHASE4
Paid for by
National Institute of Mental Health (NIMH)
Finished
2021-10-07
Health conditions
Anxiety Disorder
Who could join
Anyone
Ages
18 Years – 50 Years
Average age
Not reported
Age 65+
0%
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
White 49.2% · Black / African American 25% · Asian 14.1% · Not reported 6.3% · More than one race 4.7% · American Indian / Alaska Native 0.8% · Native Hawaiian / Pacific Islander 0%

Women left out

  • Age limit under 65

    Older women were turned away, even though they often take this medicine.

    “Maximum age: 50 Years.”
  • No pregnant women

    Women who were pregnant could not join.

    “Pregnancy or positive pregnancy test”
  • No breastfeeding moms

    Women who were breastfeeding could not join.

    “Breastfeeding”
  • No seizures

    Women with epilepsy or past seizures were turned away.

    “Any significant medical or neurological problems (e.g. cardiovascular illness, respiratory illness, neurologic illness, seizure, etc.)”
  • No mental health conditions

    Women with depression, bipolar disorder or other mental health conditions were turned away.

    “A first-degree family history of mania, schizophrenia, or other psychoses based on verbal reports”

Study titles and rules are shown in their original English.